Results 11 to 20 of about 8,822 (164)

Cetirizine a histamine H1 receptor antagonist improves viral myocarditis

open access: yesJournal of Inflammation, 2010
Background We showed that mast cells played a critical role in the progression of heart failure induced by pressure overload and viral myocarditis in mice.
Yamamoto Kanjo   +2 more
doaj   +2 more sources

Cetirizine-Induced atrial fibrillation

open access: yesArchives of Medicine and Health Sciences, 2016
Atrial fibrillation (AF) is the most common observed arrhythmia in clinical practice. In the literature, AF events associated with drug induction are available.
Altuğ Osken   +6 more
doaj   +2 more sources

Anticholinergic Syndrome Due to Cetirizine Overdose: Case Report [PDF]

open access: yesJournal of Agromedicine and Medical Sciences (AMS)
Anticholinergic toxicity can be the result of antihistamines use. Anticholinergic toxicity is pretty rare in second-generation antihistamines such as cetirizine. Using cetirizine in unreasonable doses will cause side effects.
Irawan Fajar Kusuma   +2 more
doaj   +2 more sources

APPLICATION EXPERIENCE OF CETIRIZINE SYRUP IN THE TREATMENT OF ATOPIC DERMATITIS AMONG CHILDREN

open access: yesПедиатрическая фармакология, 2007
The article gives the findings of the scientific research, whose purpose was to study the impact of cetirizine syrup (Zodiac, Zentiva, Czech Republic) on the run of atopic dermatitis among 36 children aged between 2 and 6 years old.
I.V. Makarova   +4 more
doaj   +4 more sources

Assessment of Different Cetirizine Dosing Strategies on Seasonal Allergic Rhinitis Symptoms: Findings of Two Randomized Trials

open access: yesAllergy & Rhinology, 2018
Background Cetirizine has been shown to be effective for relief of seasonal allergic rhinitis (SAR) symptoms. Allergic rhinitis symptoms have been reported to have circadian variations, with symptoms tending to be most bothersome overnight and in the ...
Eduardo R. Urdaneta MD   +4 more
doaj   +2 more sources

Phase III trials examining the efficacy of cetirizine ophthalmic solution 0.24% compared to vehicle for the treatment of allergic conjunctivitis in the conjunctival allergen challenge model

open access: yesClinical Ophthalmology, 2018
Edward J Meier,1 Gail L Torkildsen,2 Paul J Gomes,3 Mark C Jasek4 1Apex Eye, Mason, OH, USA; 2Andover Eye, Andover, MA, USA; 3Allergy, Ora, Inc., Andover, MA, USA; 4Eyevance Pharmaceuticals, TX, USA Purpose: The purpose of these Phase III studies was ...
Meier EJ   +3 more
doaj   +1 more source

Anti-Allergic Potentials of Actinodaphne angustifolia: Integrated In Vivo Evaluation and In Silico Analysis of Bioactive Compounds. [PDF]

open access: yesChem Biodivers
Actinodaphne angustifolia leaf extract exhibited significant anti‐allergic activity in a TDI‐induced mouse model, reducing sneezing, nasal scratching, nasal scores, WBC counts, and serum IgE levels. The extract was non‐toxic and rich in bioactive polyphenols, particularly (−) epicatechin and rutin hydrate.
Acharyya RN   +9 more
europepmc   +2 more sources

Comparison of Loratadine and Cetirizine in Perennial Allergic Rhinitis [PDF]

open access: yesNovelty in Biomedicine, 2015
Background: Allergic rhinitis (AR) represents a global health problem, affecting 5-50% of the population worldwide and numerous classes of pharmacological agents are available for its treatment.
Ali Eftekharian, Kiarash Nejatpoor
doaj   +2 more sources

Rebound Pruritus and Urticaria After Discontinuation of Chronic Antihistamine Use-A Scoping Review. [PDF]

open access: yesClin Exp Allergy
Rebound pruritus and urticaria have been reported after discontinuation of chronic cetirizine or levocetirizine use only. Symptoms typically occur within 0.5–5 days after stopping therapy and appear more frequently reported in female patients. Re‐initiation of antihistamines is the most commonly effective management strategy, highlighting the need for ...
Seng JJB, Oka P, Tan NC.
europepmc   +2 more sources

Remibrutinib as a Therapeutic Option for Solar Urticaria [PDF]

open access: yesPhotodermatol Photoimmunol Photomed
Photodermatology, Photoimmunology &Photomedicine, Volume 42, Issue 6, November 2026.
Mijares J   +3 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy